The International Generic and Biosimilar Medicines Association releases policy paper

Sep 24, 2020

The International Generic and Biosimilar Medicines Association (IGBA) released a new policy paper which calls for the streamlining of biosimilar regulatory requirements, and renewed efforts in informing and educating healthcare community stakeholders.

Print Page Mail Article